MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.
Saved in:
| Title: | MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence. |
|---|---|
| Authors: | Telang G; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: gaurangtelang98@gmail.com., Mishra S; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: smritimishra44@gmail.com., Sureshbabu A; School of Bioengineering, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu 600073, India. Electronic address: anuragsureshbabu@gmail.com., Kulkarni S; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: samkul1823@gmail.com., Joshi S; Acuere Biosciences Pvt. Ltd., Pune, Maharashtra 411043, India. Electronic address: drjoshisr@gmail.com., Singh R; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: rsingh1@mum.amity.edu. |
| Source: | Current problems in cancer [Curr Probl Cancer] 2025 Oct; Vol. 58, pp. 101237. Date of Electronic Publication: 2025 Jul 30. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
